nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrochlorothiazide—Blood uric acid increased—Methotrexate—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Hydrochlorothiazide—Rhinitis—Mitoxantrone—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Hydrochlorothiazide—Hypersensitivity—Teniposide—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Hydrochlorothiazide—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Hydrochlorothiazide—Flushing—Carmustine—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Hydrochlorothiazide—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Hydrochlorothiazide—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Hydrochlorothiazide—Anaemia—Bleomycin—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Hydrochlorothiazide—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Hydrochlorothiazide—Asthenia—Teniposide—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Hydrochlorothiazide—Malaise—Bleomycin—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Hydrochlorothiazide—Pruritus—Teniposide—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Hydrochlorothiazide—Arrhythmia—Carmustine—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Hydrochlorothiazide—Leukopenia—Bleomycin—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Hydrochlorothiazide—Alopecia—Carmustine—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Hydrochlorothiazide—Body temperature increased—Fludarabine—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Hydrochlorothiazide—Erythema—Carmustine—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Hydrochlorothiazide—Cough—Bleomycin—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Hydrochlorothiazide—Aplastic anaemia—Methotrexate—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Hydrochlorothiazide—Diarrhoea—Teniposide—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Hydrochlorothiazide—Chest pain—Bleomycin—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Hydrochlorothiazide—Myalgia—Bleomycin—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Hydrochlorothiazide—Alopecia—Vincristine—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Hydrochlorothiazide—Back pain—Carmustine—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Hydrochlorothiazide—Discomfort—Bleomycin—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Hydrochlorothiazide—Ecchymosis—Methotrexate—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Hydrochlorothiazide—Urine output increased—Methotrexate—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Hydrochlorothiazide—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Hydrochlorothiazide—Alopecia—Mitoxantrone—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Hydrochlorothiazide—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Hydrochlorothiazide—Confusional state—Bleomycin—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Hydrochlorothiazide—Vision blurred—Carmustine—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Hydrochlorothiazide—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Hydrochlorothiazide—Tremor—Carmustine—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Hydrochlorothiazide—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Hydrochlorothiazide—Oedema—Bleomycin—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Hydrochlorothiazide—Erythema—Mitoxantrone—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Hydrochlorothiazide—Anaemia—Carmustine—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Hydrochlorothiazide—Back pain—Vincristine—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Hydrochlorothiazide—Vomiting—Teniposide—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Hydrochlorothiazide—Agitation—Carmustine—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Hydrochlorothiazide—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Hydrochlorothiazide—Asthenia—Fludarabine—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Hydrochlorothiazide—Rash—Teniposide—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Hydrochlorothiazide—Dermatitis—Teniposide—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Hydrochlorothiazide—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Hydrochlorothiazide—Headache—Teniposide—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Hydrochlorothiazide—Pruritus—Fludarabine—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Hydrochlorothiazide—Back pain—Mitoxantrone—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Hydrochlorothiazide—Leukopenia—Carmustine—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Hydrochlorothiazide—Anorexia—Bleomycin—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Hydrochlorothiazide—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Hydrochlorothiazide—Anaemia—Vincristine—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Hydrochlorothiazide—Agitation—Vincristine—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Hydrochlorothiazide—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Hydrochlorothiazide—Photosensitivity—Methotrexate—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Hydrochlorothiazide—Polyuria—Methotrexate—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Hydrochlorothiazide—Hypotension—Bleomycin—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Hydrochlorothiazide—Diarrhoea—Fludarabine—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Hydrochlorothiazide—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Hydrochlorothiazide—Nausea—Teniposide—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Hydrochlorothiazide—Anaemia—Mitoxantrone—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Hydrochlorothiazide—Vertigo—Vincristine—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Hydrochlorothiazide—Leukopenia—Vincristine—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Hydrochlorothiazide—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Hydrochlorothiazide—Chest pain—Carmustine—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Hydrochlorothiazide—Myalgia—Carmustine—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Hydrochlorothiazide—Anxiety—Carmustine—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Hydrochlorothiazide—Paraesthesia—Bleomycin—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Hydrochlorothiazide—Malaise—Mitoxantrone—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Hydrochlorothiazide—Dyspnoea—Bleomycin—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Hydrochlorothiazide—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Hydrochlorothiazide—Confusional state—Carmustine—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Hydrochlorothiazide—Oedema—Carmustine—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Hydrochlorothiazide—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Hydrochlorothiazide—Decreased appetite—Bleomycin—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Hydrochlorothiazide—Myalgia—Vincristine—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Hydrochlorothiazide—Visual disturbance—Methotrexate—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Hydrochlorothiazide—Cough—Mitoxantrone—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Hydrochlorothiazide—Vomiting—Fludarabine—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Hydrochlorothiazide—Rash—Fludarabine—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Hydrochlorothiazide—Dermatitis—Fludarabine—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Hydrochlorothiazide—Pain—Bleomycin—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Hydrochlorothiazide—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Hydrochlorothiazide—Headache—Fludarabine—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Hydrochlorothiazide—Tachycardia—Carmustine—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Hydrochlorothiazide—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Hydrochlorothiazide—Chest pain—Mitoxantrone—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Hydrochlorothiazide—Myalgia—Mitoxantrone—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Hydrochlorothiazide—Anxiety—Mitoxantrone—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Hydrochlorothiazide—Discomfort—Mitoxantrone—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Hydrochlorothiazide—Oedema—Vincristine—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Hydrochlorothiazide—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Hydrochlorothiazide—Anorexia—Carmustine—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Hydrochlorothiazide—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Hydrochlorothiazide—Confusional state—Mitoxantrone—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Hydrochlorothiazide—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Hydrochlorothiazide—Hypotension—Carmustine—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Hydrochlorothiazide—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Hydrochlorothiazide—Oedema—Mitoxantrone—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Hydrochlorothiazide—Nausea—Fludarabine—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Hydrochlorothiazide—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Hydrochlorothiazide—Shock—Mitoxantrone—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Hydrochlorothiazide—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Hydrochlorothiazide—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Hydrochlorothiazide—Urticaria—Bleomycin—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Hydrochlorothiazide—Anorexia—Vincristine—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Hydrochlorothiazide—Tachycardia—Mitoxantrone—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Hydrochlorothiazide—Body temperature increased—Bleomycin—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Hydrochlorothiazide—Insomnia—Carmustine—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Hydrochlorothiazide—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Hydrochlorothiazide—Paraesthesia—Carmustine—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Hydrochlorothiazide—Mood swings—Methotrexate—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Hydrochlorothiazide—Hypotension—Vincristine—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Hydrochlorothiazide—Dyspnoea—Carmustine—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Hydrochlorothiazide—Somnolence—Carmustine—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Hydrochlorothiazide—Anorexia—Mitoxantrone—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Hydrochlorothiazide—Ataxia—Methotrexate—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Hydrochlorothiazide—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Hydrochlorothiazide—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Hydrochlorothiazide—Decreased appetite—Carmustine—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Hydrochlorothiazide—Hypotension—Mitoxantrone—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Hydrochlorothiazide—Insomnia—Vincristine—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Hydrochlorothiazide—Paraesthesia—Vincristine—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Hydrochlorothiazide—Pain—Carmustine—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Hydrochlorothiazide—Constipation—Carmustine—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Hydrochlorothiazide—Breast disorder—Methotrexate—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Hydrochlorothiazide—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Hydrochlorothiazide—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Hydrochlorothiazide—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Hydrochlorothiazide—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Hydrochlorothiazide—Decreased appetite—Vincristine—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Hydrochlorothiazide—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Hydrochlorothiazide—Somnolence—Mitoxantrone—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Hydrochlorothiazide—Feeling abnormal—Carmustine—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Hydrochlorothiazide—Fatigue—Vincristine—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Hydrochlorothiazide—Asthenia—Bleomycin—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Hydrochlorothiazide—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Hydrochlorothiazide—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Hydrochlorothiazide—Pain—Vincristine—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Hydrochlorothiazide—Constipation—Vincristine—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Hydrochlorothiazide—Pruritus—Bleomycin—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Hydrochlorothiazide—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Hydrochlorothiazide—Fatigue—Mitoxantrone—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Hydrochlorothiazide—Pancreatitis—Methotrexate—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Hydrochlorothiazide—Pain—Mitoxantrone—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Hydrochlorothiazide—Constipation—Mitoxantrone—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Hydrochlorothiazide—Body temperature increased—Carmustine—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Hydrochlorothiazide—Abdominal pain—Carmustine—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Hydrochlorothiazide—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Hydrochlorothiazide—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Hydrochlorothiazide—Dysuria—Methotrexate—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Hydrochlorothiazide—Neutropenia—Methotrexate—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Hydrochlorothiazide—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Hydrochlorothiazide—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Hydrochlorothiazide—Abdominal pain—Vincristine—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Hydrochlorothiazide—Body temperature increased—Vincristine—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Hydrochlorothiazide—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Hydrochlorothiazide—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Hydrochlorothiazide—Urticaria—Mitoxantrone—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Hydrochlorothiazide—Hypersensitivity—Carmustine—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Hydrochlorothiazide—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Hydrochlorothiazide—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Hydrochlorothiazide—Pneumonia—Methotrexate—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Hydrochlorothiazide—Vomiting—Bleomycin—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Hydrochlorothiazide—Rash—Bleomycin—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Hydrochlorothiazide—Dermatitis—Bleomycin—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Hydrochlorothiazide—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Hydrochlorothiazide—Asthenia—Carmustine—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Hydrochlorothiazide—Renal failure—Methotrexate—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Hydrochlorothiazide—Conjunctivitis—Methotrexate—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Hydrochlorothiazide—Hypersensitivity—Vincristine—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Hydrochlorothiazide—Sweating—Methotrexate—lymphatic system cancer	0.001	0.001	CcSEcCtD
Hydrochlorothiazide—Haematuria—Methotrexate—lymphatic system cancer	0.000995	0.000995	CcSEcCtD
Hydrochlorothiazide—Epistaxis—Methotrexate—lymphatic system cancer	0.000984	0.000984	CcSEcCtD
Hydrochlorothiazide—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000984	0.000984	CcSEcCtD
Hydrochlorothiazide—Asthenia—Vincristine—lymphatic system cancer	0.000984	0.000984	CcSEcCtD
Hydrochlorothiazide—Diarrhoea—Carmustine—lymphatic system cancer	0.000983	0.000983	CcSEcCtD
Hydrochlorothiazide—Nausea—Bleomycin—lymphatic system cancer	0.000978	0.000978	CcSEcCtD
Hydrochlorothiazide—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000974	0.000974	CcSEcCtD
Hydrochlorothiazide—Asthenia—Mitoxantrone—lymphatic system cancer	0.000959	0.000959	CcSEcCtD
Hydrochlorothiazide—Dizziness—Carmustine—lymphatic system cancer	0.00095	0.00095	CcSEcCtD
Hydrochlorothiazide—Diarrhoea—Vincristine—lymphatic system cancer	0.000939	0.000939	CcSEcCtD
Hydrochlorothiazide—Hepatitis—Methotrexate—lymphatic system cancer	0.000937	0.000937	CcSEcCtD
Hydrochlorothiazide—Pharyngitis—Methotrexate—lymphatic system cancer	0.00093	0.00093	CcSEcCtD
Hydrochlorothiazide—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000914	0.000914	CcSEcCtD
Hydrochlorothiazide—Vomiting—Carmustine—lymphatic system cancer	0.000914	0.000914	CcSEcCtD
Hydrochlorothiazide—Dizziness—Vincristine—lymphatic system cancer	0.000907	0.000907	CcSEcCtD
Hydrochlorothiazide—Rash—Carmustine—lymphatic system cancer	0.000906	0.000906	CcSEcCtD
Hydrochlorothiazide—Dermatitis—Carmustine—lymphatic system cancer	0.000905	0.000905	CcSEcCtD
Hydrochlorothiazide—Visual impairment—Methotrexate—lymphatic system cancer	0.000903	0.000903	CcSEcCtD
Hydrochlorothiazide—Headache—Carmustine—lymphatic system cancer	0.0009	0.0009	CcSEcCtD
Hydrochlorothiazide—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000886	0.000886	CcSEcCtD
Hydrochlorothiazide—Tinnitus—Methotrexate—lymphatic system cancer	0.000874	0.000874	CcSEcCtD
Hydrochlorothiazide—Vomiting—Vincristine—lymphatic system cancer	0.000872	0.000872	CcSEcCtD
Hydrochlorothiazide—Rash—Vincristine—lymphatic system cancer	0.000865	0.000865	CcSEcCtD
Hydrochlorothiazide—Dermatitis—Vincristine—lymphatic system cancer	0.000864	0.000864	CcSEcCtD
Hydrochlorothiazide—Headache—Vincristine—lymphatic system cancer	0.000859	0.000859	CcSEcCtD
Hydrochlorothiazide—Nausea—Carmustine—lymphatic system cancer	0.000854	0.000854	CcSEcCtD
Hydrochlorothiazide—Vomiting—Mitoxantrone—lymphatic system cancer	0.000849	0.000849	CcSEcCtD
Hydrochlorothiazide—Rash—Mitoxantrone—lymphatic system cancer	0.000842	0.000842	CcSEcCtD
Hydrochlorothiazide—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000842	0.000842	CcSEcCtD
Hydrochlorothiazide—Headache—Mitoxantrone—lymphatic system cancer	0.000837	0.000837	CcSEcCtD
Hydrochlorothiazide—Alopecia—Methotrexate—lymphatic system cancer	0.000828	0.000828	CcSEcCtD
Hydrochlorothiazide—Erythema—Methotrexate—lymphatic system cancer	0.000816	0.000816	CcSEcCtD
Hydrochlorothiazide—Nausea—Vincristine—lymphatic system cancer	0.000815	0.000815	CcSEcCtD
Hydrochlorothiazide—Dysgeusia—Methotrexate—lymphatic system cancer	0.000799	0.000799	CcSEcCtD
Hydrochlorothiazide—Nausea—Mitoxantrone—lymphatic system cancer	0.000794	0.000794	CcSEcCtD
Hydrochlorothiazide—Back pain—Methotrexate—lymphatic system cancer	0.000789	0.000789	CcSEcCtD
Hydrochlorothiazide—Vision blurred—Methotrexate—lymphatic system cancer	0.000769	0.000769	CcSEcCtD
Hydrochlorothiazide—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000757	0.000757	CcSEcCtD
Hydrochlorothiazide—Anaemia—Methotrexate—lymphatic system cancer	0.000754	0.000754	CcSEcCtD
Hydrochlorothiazide—Malaise—Methotrexate—lymphatic system cancer	0.000735	0.000735	CcSEcCtD
Hydrochlorothiazide—Vertigo—Methotrexate—lymphatic system cancer	0.000733	0.000733	CcSEcCtD
Hydrochlorothiazide—Leukopenia—Methotrexate—lymphatic system cancer	0.00073	0.00073	CcSEcCtD
Hydrochlorothiazide—Cough—Methotrexate—lymphatic system cancer	0.000712	0.000712	CcSEcCtD
Hydrochlorothiazide—Arthralgia—Methotrexate—lymphatic system cancer	0.000694	0.000694	CcSEcCtD
Hydrochlorothiazide—Myalgia—Methotrexate—lymphatic system cancer	0.000694	0.000694	CcSEcCtD
Hydrochlorothiazide—Chest pain—Methotrexate—lymphatic system cancer	0.000694	0.000694	CcSEcCtD
Hydrochlorothiazide—Discomfort—Methotrexate—lymphatic system cancer	0.000686	0.000686	CcSEcCtD
Hydrochlorothiazide—Confusional state—Methotrexate—lymphatic system cancer	0.000671	0.000671	CcSEcCtD
Hydrochlorothiazide—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000666	0.000666	CcSEcCtD
Hydrochlorothiazide—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000652	0.000652	CcSEcCtD
Hydrochlorothiazide—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000643	0.000643	CcSEcCtD
Hydrochlorothiazide—Anorexia—Methotrexate—lymphatic system cancer	0.000634	0.000634	CcSEcCtD
Hydrochlorothiazide—Hypotension—Methotrexate—lymphatic system cancer	0.000622	0.000622	CcSEcCtD
Hydrochlorothiazide—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000606	0.000606	CcSEcCtD
Hydrochlorothiazide—Insomnia—Methotrexate—lymphatic system cancer	0.000602	0.000602	CcSEcCtD
Hydrochlorothiazide—Paraesthesia—Methotrexate—lymphatic system cancer	0.000598	0.000598	CcSEcCtD
Hydrochlorothiazide—Dyspnoea—Methotrexate—lymphatic system cancer	0.000593	0.000593	CcSEcCtD
Hydrochlorothiazide—Somnolence—Methotrexate—lymphatic system cancer	0.000592	0.000592	CcSEcCtD
Hydrochlorothiazide—Dyspepsia—Methotrexate—lymphatic system cancer	0.000586	0.000586	CcSEcCtD
Hydrochlorothiazide—Decreased appetite—Methotrexate—lymphatic system cancer	0.000579	0.000579	CcSEcCtD
Hydrochlorothiazide—Fatigue—Methotrexate—lymphatic system cancer	0.000574	0.000574	CcSEcCtD
Hydrochlorothiazide—Pain—Methotrexate—lymphatic system cancer	0.000569	0.000569	CcSEcCtD
Hydrochlorothiazide—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000549	0.000549	CcSEcCtD
Hydrochlorothiazide—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000544	0.000544	CcSEcCtD
Hydrochlorothiazide—Urticaria—Methotrexate—lymphatic system cancer	0.000529	0.000529	CcSEcCtD
Hydrochlorothiazide—Body temperature increased—Methotrexate—lymphatic system cancer	0.000526	0.000526	CcSEcCtD
Hydrochlorothiazide—Abdominal pain—Methotrexate—lymphatic system cancer	0.000526	0.000526	CcSEcCtD
Hydrochlorothiazide—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00049	0.00049	CcSEcCtD
Hydrochlorothiazide—Asthenia—Methotrexate—lymphatic system cancer	0.000478	0.000478	CcSEcCtD
Hydrochlorothiazide—Pruritus—Methotrexate—lymphatic system cancer	0.000471	0.000471	CcSEcCtD
Hydrochlorothiazide—Diarrhoea—Methotrexate—lymphatic system cancer	0.000455	0.000455	CcSEcCtD
Hydrochlorothiazide—Dizziness—Methotrexate—lymphatic system cancer	0.00044	0.00044	CcSEcCtD
Hydrochlorothiazide—Vomiting—Methotrexate—lymphatic system cancer	0.000423	0.000423	CcSEcCtD
Hydrochlorothiazide—Rash—Methotrexate—lymphatic system cancer	0.00042	0.00042	CcSEcCtD
Hydrochlorothiazide—Dermatitis—Methotrexate—lymphatic system cancer	0.000419	0.000419	CcSEcCtD
Hydrochlorothiazide—Headache—Methotrexate—lymphatic system cancer	0.000417	0.000417	CcSEcCtD
Hydrochlorothiazide—Nausea—Methotrexate—lymphatic system cancer	0.000395	0.000395	CcSEcCtD
